Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06540287 · ClinicalTrials.gov registry record
Molecular Optimization Via Exercise (MOVE)
A clinical trial of Aging, sponsored by Buck Institute for Research on Aging.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06540287: Recruiting study of Aging, sponsored by Buck Institute for Research on Aging.
NCT06540287 is a study of Aging that is actively recruiting participants, run by Buck Institute for Research on Aging. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06540287, a study of Aging, is actively recruiting participants, sponsored by Buck Institute for Research on Aging.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.
Primary Outcome
Differences between athletes and sedentary in muscle spatial transcriptomic between OEA and HOA groups
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
California
- Buck Institute for Research on Aging - Novato
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2027-05 |
What NCT06540287 shows while recruiting
NCT06540287 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT06540287 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06540287 about?
NCT06540287 is a clinical study titled "Molecular Optimization Via Exercise (MOVE)". This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function t...
What is the current status of trial NCT06540287?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-09-19. Estimated completion is 2027-05.
What conditions does trial NCT06540287 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT06540287?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT06540287?
This trial is sponsored by Buck Institute for Research on Aging, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06540287 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06540287's enrollment target sits among peer trials
80 108th of 262 higher than 149 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI